title: Effects of a single dose inhaled corticosteroid on the dynamics of airway obstruction after exercise.
abstract: BACKGROUND
  Exercise-induced bronchoconstriction (EIB) is defined as a transient narrowing of the airways induced by exercise. Repetitive measurements of spirometric parameters, such as FEV(1) and expiratory flows, and forced oscillation technique (FOT) measurements can be used to analyze the dynamics of EIB. A single high dose of fluticasone propionate (FP) protects against EIB. The aim of the study was to analyze the effect of FP on the dynamics of exercise-induced airway narrowing as measured with FOT and spirometry.
  
  
  METHODS
  Twelve children performed an exercise challenge on 2 separate days, 4 hr after inhalation of 1 mg FP (pressurized metered dose inhaler) or a placebo. Before and after the exercise flow-volume loops as well as the FOT (frequency range: 4-32 Hz) were measured.
  
  
  RESULTS
  The FEV(1) , and FEF(50) fell significantly after exercise within groups; the peak fall in FEV(1) after FP was significantly smaller than after placebo (respectively, 19.3 ± 14.6% and 29.2 ± 14.8%, P = 0.03, 95% CI: 0.9-18.8%). The fall in FEV(1) and FEF(50) peaked 3 min after exercise and showed a subsequent partial recovery. The fall in the FEV(1) /FVC ratio showed a later peak fall (12 min after exercise). The resistance increased while the reactance decreased significantly after exercise. FP significantly decreased the maximal increase in Rrs(6) when compared to the placebo (respectively 176.5 ± 59.1% and 201.0 ± 63.8%, P = 0.05, 95% CI: 0.5-48.7%). The maximal decrease in Xrs(6) was not significantly affected by FP (P = 0.06).
  
  
  CONCLUSIONS
  Repetitive spirometric and FOT measurements after exercise show a rapid narrowing and steady recovery of the patency of the conducting airways, and indicate a delayed and prolonged recovery of the smaller airways. A single high dose of inhaled FP seems to employ its effect mainly in the conducting airways.
authors.affiliation: Department of Pediatrics, Medisch Spectrum Twente, Enschede, The Netherlands. jeandriessen@hotmail.com
authors.forename: J M M
authors.initials: JM
authors.lastname: Driessen
authors.forename: H
authors.initials: H
authors.lastname: Nieland
authors.forename: J A M
authors.initials: JA
authors.lastname: van der Palen
authors.forename: W M C
authors.initials: WM
authors.lastname: van Aalderen
authors.forename: B J
authors.initials: BJ
authors.lastname: Thio
authors.forename: F H C
authors.initials: FH
authors.lastname: de Jongh
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000402:Airway Obstruction / Q000188:drug therapy*; D000730:Androstadienes / Q000008:administration & dosage*; D001250:Asthma, Exercise-Induced / Q000188:drug therapy*; D016084:Bronchoconstriction / Q000187:drug effects* / Q000502:physiology; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D002648:Child; D018592:Cross-Over Studies; D005260:Female; D000068298:Fluticasone; D006801:Humans; D008297:Male; D012129:Respiratory Function Tests
chemical_list: D000730:Androstadienes; D001993:Bronchodilator Agents; D000068298:Fluticasone